Home › Funds › Sofinnova Investments, Inc. › PHVS

Sofinnova Investments, Inc. position in PHVS

PHARVARIS N V · Health Care

Sofinnova Investments, Inc. reported holding 881,299 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$30.5M, representing 1.62% of its reported portfolio and ranking #22 among its reported holdings. Sofinnova Investments, Inc. has disclosed PHVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)881.30K sh
Reported value held$30.48M
Portfolio Weight1.62%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s PHVS position evolved

Sofinnova Investments, Inc. first disclosed a stake in PHVS in Q4 2023 at 510,441 shares (US$14.3M). The position peaked in Q2 2026 at 881,299 shares, worth US$30.5M. Across 11 filings, Sofinnova Investments, Inc. increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 881,299 shares valued at US$30.5M — an increase of 62,971 shares quarter over quarter.. Notable position changes include a 26% increase in Q3 2025 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 510.44K $14.32M New
Q1 2024 584.67K $13.51M Add
Q2 2024 601.53K $11.31M Add
Q3 2024 600.30K $11.12M Hold
Q4 2024 560.72K $10.75M Reduce
Q1 2025 593.40K $9.32M Add
Q2 2025 585.53K $10.31M Reduce
Q3 2025 739.88K $18.46M Add
Q4 2025 745.17K $20.68M Add
Q1 2026 818.33K $23.12M Add
Q2 2026 881.30K $30.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has Sofinnova Investments, Inc. held PHVS?

Sofinnova Investments, Inc. has disclosed PHVS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Sofinnova Investments, Inc.'s current position in PHVS?

As of Q2 2026, Sofinnova Investments, Inc. holds 881.30K shares of PHVS (PHARVARIS N V), valued at $30.48M, representing 1.62% of its reported portfolio and ranking #22.

Has Sofinnova Investments, Inc. been buying or selling PHVS?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. increased its position in PHVS. The position peaked in Q2 2026 at 881.30K shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.